Agenus (AGEN) director Brian Corvese receives 100,000 stock options at $7.78
Rhea-AI Filing Summary
AGENUS INC director Brian Corvese received a compensatory grant of 100,000 stock options on 2026-08-05. The options have an exercise price of $7.78 per share, expire on 2036-08-05, and were awarded under the company’s 2019 Amended and Restated Equity Incentive Plan. They vest over three years, with one-third vesting on the first anniversary of the grant date and the remaining two-thirds vesting in two equal annual installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Corvese Brian
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option F1 | 100,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 100,000 shares (Direct)
Footnotes (1)
- F1. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter.
Key Figures
Stock options granted: 100,000 options
Exercise price: $7.78 per share
Expiration date: 2036-08-05
+2 more
5 metrics
Stock options granted
100,000 options
Grant to director Brian Corvese on 2026-08-05
Exercise price
$7.78 per share
Exercise price of the granted stock options
Expiration date
2036-08-05
Option term under the 2019 Amended and Restated Equity Incentive Plan
Shares underlying options
100,000 shares
Common stock underlying the stock option grant
Vesting period
3 years
One-third after one year, remaining two-thirds in two annual installments
Key Terms
Stock Option, Equity Incentive Plan, vesting
3 terms
Stock Option financial
"The security reported is a Stock Option exercisable for common stock."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Equity Incentive Plan financial
"Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
vesting financial
"Options vest over three years, with one-third vesting on the first anniversary."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What insider transaction did AGEN (AGENUS INC) report for Brian Corvese?
AGEN reported that director Brian Corvese received a grant of 100,000 stock options on 2026-08-05 as part of his compensation, rather than a market purchase or sale of existing shares.
What are the key terms of Brian Corvese’s new AGEN stock options?
The grant consists of 100,000 stock options with an exercise price of $7.78 per share, expiring on 2036-08-05. The options relate to AGENUS INC common stock and are held directly.
How do Brian Corvese’s AGEN stock options vest over time?
The options vest over three years. One-third vests on the first anniversary of the grant date, and the remaining two-thirds vest in two equal annual installments thereafter, subject to the plan’s terms.
Under which equity plan were the AGEN options granted to Brian Corvese?
The options were awarded under the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, which governs equity-based compensation such as stock option grants to directors and other eligible participants.
How many AGEN stock options does Brian Corvese hold after this grant?
Following this transaction, Brian Corvese holds 100,000 stock options reported in this filing. These options give him the right to buy an equivalent number of AGENUS INC common shares at the specified exercise price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
